REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Farmastela (Lithuania)

Main Activities: Irradiation Apparatus Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: UAB Farmastela Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Farmastela is an enterprise located in Lithuania, with the main office in Vilnius. The enterprise operates in the Irradiation Apparatus Manufacturing industry. The enterprise was incorporated on November 13, 2013. It currently has a total number of 3 (2025) employees. The latest financial highlights indicate a net sales revenue increase of 48.24% in 2024. The enterprise’s net profit margin increased by 13.26% in 2024.

Headquarters
Seliu g. 13-25
Vilnius; Vilnius county; Postal Code: LT-08125

Contact Details: Purchase the UAB Farmastela report to view the information.

Basic Information
Total Employees:
Purchase the UAB Farmastela report to view the information.
Registered Capital:
Purchase the UAB Farmastela report to view the information.
Financial Auditors:
Purchase the UAB Farmastela report to view the information.
Incorporation Date:
November 13, 2013
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Farmastela report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
48.24%
Total operating revenue
48.24%
Net Profit (Loss) for the Period
156.9%
Total equity
-23.68%
Net Profit Margin
13.26%
Return on Equity (ROE)
619.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?